1 article - Page 1/1
Risque thrombotique et anticoagulation des patients hospitalisés pour une maladie à Coronavirus 2019 sévère.
Thrombotic risk and anticoagulation in patients hospitalized for severe Coronavirus 2019 disease.
Auteurs/Authors : Labbe V., Mekontso-Dessap A.
Mots-clés : COVID-19, Pneumopathie hypoxémiante, Thromboses macrovasculaires, Thromboses microvasculaires, Anticoagulation, Prévention, Evénements thrombotiques, Essais cliniques : ANTICOVID, INSPIRATION, ACTION, COVIDOSE, REMAPCAP, ATTAC, ACTIV-4
Keywords: COVID-19, Hypoxemic lung disease, Macrovascular thrombosis, Microvascular thrombosis, Anticoagulation, Prevention, Thrombotic events, Clinical trials: ANTICOVID, INSPIRATION, ACTION, COVIDOSE, REMAPCAP, ATTAC, ACTIV-4
